Cumberland Pharmaceuticals Minority Interest

Cumberland Pharmaceuticals posts a minority interest of $-330K as of March 2026. That compares with $-320K in the prior-year period — down 5.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Cumberland Pharmaceuticals's minority interest was $-320K. The latest reading is $-330K — a 5.4% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Minority Interest is one piece of Cumberland Pharmaceuticals's financial statement story. At $-330K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CPIX's minority interest usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Cumberland Pharmaceuticals's other metric pages and overview cover the third.

Judging Cumberland Pharmaceuticals against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in minority interest easier to interpret. Start with $-330K here, then scan peer and history charts to see if the gap is persistent.